{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:32:23Z","timestamp":1786365143836,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Research Grants Council General Research Fund Hong Kong Research Grants Council Collaborative Research Fund the Health@InnoHK to CVVT, Innovation and Technology Commission of Hong Kong"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74633-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:23:04Z","timestamp":1782732184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sialic acid-anchored haemagglutinin stalk neutralizing antibody M-SiaB enhances protection against highly pathogenic influenza H5N1\/Texas\/2024"],"prefix":"10.1038","volume":"17","author":[{"given":"Ruina","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruzhan","family":"Aldungarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-1130","authenticated-orcid":false,"given":"Pui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-7357","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9105-1009","authenticated-orcid":false,"given":"Yelim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-8912","authenticated-orcid":false,"given":"Vincent Kwok-Man","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7089-4829","authenticated-orcid":false,"given":"Chris Chung-Sing","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucetta","family":"Joselyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-8338","authenticated-orcid":false,"given":"Honglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-1552","authenticated-orcid":false,"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-6657","authenticated-orcid":false,"given":"Jasper Fuk-Woo","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-2888","authenticated-orcid":false,"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"74633_CR1","unstructured":"World Health Organization (WHO). Influenza (seasonal). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal) (2025)."},{"key":"74633_CR2","doi-asserted-by":"crossref","unstructured":"Wang, D., Zhu, W., Yang, L. & Shu, Y. The epidemiology, virology, and pathogenicity of human infections with avian influenza viruses. Cold Spring Harb. Perspect. Med. 11, a038620 (2021).","DOI":"10.1101\/cshperspect.a038620"},{"key":"74633_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nrmicro3362","volume":"12","author":"Y Shi","year":"2014","unstructured":"Shi, Y., Wu, Y., Zhang, W., Qi, J. & Gao, G. F. Enabling the \u2018host jump\u2019: structural determinants of receptor-binding specificity in influenza A viruses. Nat. Rev. Microbiol. 12, 822\u2013831 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"74633_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/bmb\/ldz036","volume":"132","author":"YT Li","year":"2019","unstructured":"Li, Y. T., Linster, M., Mendenhall, I. H., Su, Y. C. F. & Smith, G. J. D. Avian influenza viruses in humans: lessons from past outbreaks. Br. Med. Bull. 132, 81\u201395 (2019).","journal-title":"Br. Med. Bull."},{"key":"74633_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58504-z","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models. Nat. Commun. 16, 3133 (2025).","journal-title":"Nat. Commun."},{"key":"74633_CR6","volume":"8","author":"G Zhang","year":"2025","unstructured":"Zhang, G. et al. Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: a call for global surveillance and multi-target antiviral strategies. Curr. Res. Microb. Sci. 8, 100377 (2025).","journal-title":"Curr. Res. Microb. Sci."},{"key":"74633_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","volume":"634","author":"LC Caserta","year":"2024","unstructured":"Caserta, L. C. et al. Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle. Nature 634, 669\u2013676 (2024).","journal-title":"Nature"},{"key":"74633_CR8","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMc2405371","volume":"390","author":"TM Uyeki","year":"2024","unstructured":"Uyeki, T. M. et al. Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker. N. Engl. J. Med. 390, 2028\u20132029 (2024).","journal-title":"N. Engl. J. Med."},{"key":"74633_CR9","unstructured":"CDC. CDC confirms second human H5 bird flu case in Michigan; Third Case tied to dairy outbreak. https:\/\/www.cdc.gov\/media\/releases\/2024\/p0530-h5-human-case-michigan.html (2024)."},{"key":"74633_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07766-6","volume":"633","author":"AJ Eisfeld","year":"2024","unstructured":"Eisfeld, A. J. et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature 633, 426\u2013432 (2024).","journal-title":"Nature"},{"key":"74633_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","volume":"24","author":"D Corti","year":"2017","unstructured":"Corti, D. et al. Tackling influenza with broadly neutralizing antibodies. Curr. Opin. Virol. 24, 60\u201369 (2017).","journal-title":"Curr. Opin. Virol."},{"key":"74633_CR12","doi-asserted-by":"crossref","unstructured":"Nuwarda, R. F., Alharbi, A. A. & Kayser, V. An overview of influenza viruses and vaccines. Vaccines 9, 1032 (2021).","DOI":"10.3390\/vaccines9091032"},{"key":"74633_CR13","doi-asserted-by":"crossref","unstructured":"Wu, N. C. & Wilson, I. A. Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb. Perspect. Med. 10, a038778 (2020).","DOI":"10.1101\/cshperspect.a038778"},{"key":"74633_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"74633_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4614","volume":"5","author":"PS Lee","year":"2014","unstructured":"Lee, P. S. et al. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat. Commun. 5, 3614 (2014).","journal-title":"Nat. Commun."},{"key":"74633_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"74633_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"74633_CR18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"74633_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105785","volume":"221","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Broadly neutralizing antibodies to combat influenza virus infection. Antiviral Res. 221, 105785 (2024).","journal-title":"Antiviral Res."},{"key":"74633_CR20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.aaz5143","volume":"368","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. et al. Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses. Science 368, 1335\u20131340 (2020).","journal-title":"Science"},{"key":"74633_CR21","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41591-020-0937-x","volume":"26","author":"JK Park","year":"2020","unstructured":"Park, J. K. et al. Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model. Nat. Med. 26, 1240\u20131246 (2020).","journal-title":"Nat. Med."},{"key":"74633_CR22","doi-asserted-by":"crossref","unstructured":"Roubidoux, E. K. et al. Mutations in the hemagglutinin stalk domain do not permit escape from a protective, stalk-based vaccine-induced immune response in the mouse model. mBio 12, e03617-20 (2021).","DOI":"10.1128\/mBio.03617-20"},{"key":"74633_CR23","doi-asserted-by":"crossref","unstructured":"Wagner, K. et al. Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity. Proc. Natl. Acad. Sci. USA 111, 16820\u201316825 (2014).","DOI":"10.1073\/pnas.1408605111"},{"key":"74633_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01085-24","volume":"15","author":"KE Ramos","year":"2024","unstructured":"Ramos, K. E. et al. Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase. mBio 15, e0108524 (2024).","journal-title":"mBio"},{"key":"74633_CR25","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1016\/j.ymthe.2024.07.023","volume":"32","author":"R Moirangthem","year":"2024","unstructured":"Moirangthem, R. et al. Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity. Mol. Ther. 32, 3712\u20133728 (2024).","journal-title":"Mol. Ther."},{"key":"74633_CR26","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1073\/pnas.1404205111","volume":"111","author":"H Connaris","year":"2014","unstructured":"Connaris, H. et al. Prevention of influenza by targeting host receptors using engineered proteins. Proc. Natl. Acad. Sci. USA 111, 6401\u20136406 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74633_CR27","doi-asserted-by":"publisher","first-page":"18002","DOI":"10.1073\/pnas.2008190117","volume":"117","author":"P Wang","year":"2020","unstructured":"Wang, P. et al. Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo. Proc. Natl. Acad. Sci. USA 117, 18002\u201318009 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74633_CR28","doi-asserted-by":"publisher","first-page":"S555","DOI":"10.1093\/infdis\/jix001","volume":"216","author":"MZ Levine","year":"2017","unstructured":"Levine, M. Z. et al. Cross-reactive antibody responses to novel H5Nx influenza viruses following homologous and heterologous prime-boost vaccination with a prepandemic stockpiled A(H5N1) vaccine in humans. J. Infect. Dis. 216, S555\u2013S559 (2017).","journal-title":"J. Infect. Dis."},{"key":"74633_CR29","doi-asserted-by":"publisher","unstructured":"Tai, C. J., Li, C. L., Tai, C. J., Wang, C. K. & Lin, L. T. Early viral entry assays for the identification and evaluation of antiviral compounds. J. Vis. Exp. https:\/\/doi.org\/10.3791\/53124 (2015).","DOI":"10.3791\/53124"},{"key":"74633_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2475836","volume":"14","author":"N Xiao","year":"2025","unstructured":"Xiao, N. et al. Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB\/c mice. Emerg. Microbes Infect. 14, 2475836 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"74633_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116069","volume":"265","author":"Y He","year":"2024","unstructured":"He, Y. et al. Broad-spectrum antiviral strategy: host-targeting antivirals against emerging and re-emerging viruses. Eur. J. Med. Chem. 265, 116069 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"74633_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106101","volume":"235","author":"A Schreiber","year":"2025","unstructured":"Schreiber, A. & Ludwig, S. Host-targeted antivirals against SARS-CoV-2 in clinical development - prospect or disappointment. Antiviral Res. 235, 106101 (2025).","journal-title":"Antiviral Res."},{"key":"74633_CR33","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1021\/acs.jmedchem.9b00091","volume":"62","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors. J. Med. Chem. 62, 4056\u20134073 (2019).","journal-title":"J. Med. Chem."},{"key":"74633_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 17, 35\u201356 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74633_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4161\/mabs.4.2.19000","volume":"4","author":"RE Kontermann","year":"2012","unstructured":"Kontermann, R. E. Dual targeting strategies with bispecific antibodies. MAbs 4, 182\u2013197 (2012).","journal-title":"MAbs"},{"key":"74633_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.tim.2016.07.005","volume":"24","author":"BR Wasik","year":"2016","unstructured":"Wasik, B. R., Barnard, K. N. & Parrish, C. R. Effects of sialic acid modifications on virus binding and infection. Trends Microbiol. 24, 991\u20131001 (2016).","journal-title":"Trends Microbiol."},{"key":"74633_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1074\/jbc.270.3.1308","volume":"270","author":"OT Keppler","year":"1995","unstructured":"Keppler, O. T. et al. Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J. Biol. Chem. 270, 1308\u20131314 (1995).","journal-title":"J. Biol. Chem."},{"key":"74633_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.virs.2022.02.005","volume":"37","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants. Virol. Sin. 37, 238\u2013247 (2022).","journal-title":"Virol. Sin."},{"key":"74633_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41586-021-03673-2","volume":"595","author":"Z Ku","year":"2021","unstructured":"Ku, Z. et al. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature 595, 718\u2013723 (2021).","journal-title":"Nature"},{"key":"74633_CR40","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1172\/JCI96764","volume":"128","author":"X Wu","year":"2018","unstructured":"Wu, X. et al. Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. J. Clin. Invest. 128, 2239\u20132251 (2018).","journal-title":"J. Clin. Invest."},{"key":"74633_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109611","volume":"36","author":"M Niu","year":"2021","unstructured":"Niu, M. et al. Tandem bispecific antibody prevents pathogenic SHIV(SF162P3CN) infection and disease progression. Cell Rep. 36, 109611 (2021).","journal-title":"Cell Rep."},{"key":"74633_CR42","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.cell.2016.05.024","volume":"165","author":"Y Huang","year":"2016","unstructured":"Huang, Y. et al. Engineered bispecific antibodies with exquisite HIV-1-neutralizing activity. Cell 165, 1621\u20131631 (2016).","journal-title":"Cell"},{"key":"74633_CR43","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.immuni.2022.10.015","volume":"55","author":"SM Moin","year":"2022","unstructured":"Moin, S. M. et al. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. Immunity 55, 2405\u20132418 e2407 (2022).","journal-title":"Immunity"},{"key":"74633_CR44","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301\u20131306 (2015).","journal-title":"Science"},{"key":"74633_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101207","volume":"53","author":"X Sun","year":"2022","unstructured":"Sun, X., Ling, Z., Yang, Z. & Sun, B. Broad neutralizing antibody-based strategies to tackle influenza. Curr. Opin. Virol. 53, 101207 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"74633_CR46","doi-asserted-by":"crossref","unstructured":"Yuanyuan, H., Zijian, G., Subiaur, S., Benegal, A. & Vahey, M. D. Antibody inhibition of influenza A virus assembly and release. J. Virol. 98, e0139823 (2024).","DOI":"10.1128\/jvi.01398-23"},{"key":"74633_CR47","doi-asserted-by":"publisher","first-page":"e0245244","DOI":"10.1371\/journal.pone.0245244","volume":"16","author":"K Sano","year":"2021","unstructured":"Sano, K. et al. An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody. PLoS ONE 16, e0245244 (2021).","journal-title":"PLoS ONE"},{"key":"74633_CR48","doi-asserted-by":"crossref","unstructured":"Chen, Y. Q., Lan, L. Y., Huang, M., Henry, C. & Wilson, P. C. Hemagglutinin stalk-reactive antibodies interfere with influenza virus neuraminidase activity by steric hindrance. J. Virol. 93, e01526-18 (2019).","DOI":"10.1128\/JVI.01526-18"},{"key":"74633_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj9534","volume":"9","author":"I Kosik","year":"2024","unstructured":"Kosik, I. et al. C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire. Sci. Immunol. 9, eadj9534 (2024).","journal-title":"Sci. Immunol."},{"key":"74633_CR50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.chom.2021.02.019","volume":"29","author":"D Zhou","year":"2021","unstructured":"Zhou, D. et al. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies. Cell Host Microbe 29, 551\u2013563 e555 (2021).","journal-title":"Cell Host Microbe"},{"key":"74633_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93493-5","volume":"15","author":"CP Octaviani","year":"2025","unstructured":"Octaviani, C. P., Huang, P., Bi-Hung, P., Gray, G. C. & Tseng, C. K. Superior replication, pathogenicity, and immune evasion of a Texas dairy cattle H5N1 virus compared to a historical avian isolate. Sci. Rep. 15, 8797 (2025).","journal-title":"Sci. Rep."},{"key":"74633_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2447614","volume":"14","author":"A Mostafa","year":"2025","unstructured":"Mostafa, A. et al. Replication kinetics, pathogenicity and virus-induced cellular responses of cattle-origin influenza A(H5N1) isolates from Texas, United States. Emerg. Microbes Infect. 14, 2447614 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"74633_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1139\/O10-017","volume":"88","author":"C Korteweg","year":"2010","unstructured":"Korteweg, C. & Gu, J. Pandemic influenza A (H1N1) virus infection and avian influenza A (H5N1) virus infection: a comparative analysis. Biochem. Cell Biol. 88, 575\u2013587 (2010).","journal-title":"Biochem. Cell Biol."},{"key":"74633_CR54","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/j.1460-2075.1992.tb05305.x","volume":"11","author":"A Stieneke-Grober","year":"1992","unstructured":"Stieneke-Grober, A. et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11, 2407\u20132414 (1992).","journal-title":"EMBO J."},{"key":"74633_CR55","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1128\/jvi.68.5.3120-3128.1994","volume":"68","author":"T Horimoto","year":"1994","unstructured":"Horimoto, T. & Kawaoka, Y. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J. Virol. 68, 3120\u20133128 (1994).","journal-title":"J. Virol."},{"key":"74633_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adz1580","volume":"18","author":"AL Beukenhorst","year":"2026","unstructured":"Beukenhorst, A. L. et al. Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114. Sci. Transl. Med. 18, eadz1580 (2026).","journal-title":"Sci. Transl. Med."},{"key":"74633_CR57","first-page":"153","volume":"82","author":"T Samji","year":"2009","unstructured":"Samji, T. Influenza A: understanding the viral life cycle. Yale J. Biol. Med. 82, 153\u2013159 (2009).","journal-title":"Yale J. Biol. Med."},{"key":"74633_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12929-019-0567-0","volume":"26","author":"JJ Shie","year":"2019","unstructured":"Shie, J. J. & Fang, J. M. Development of effective anti-influenza drugs: congeners and conjugates - a review. J. Biomed. Sci. 26, 84 (2019).","journal-title":"J. Biomed. Sci."},{"key":"74633_CR59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrmicro3346","volume":"12","author":"JE Stencel-Baerenwald","year":"2014","unstructured":"Stencel-Baerenwald, J. E., Reiss, K., Reiter, D. M., Stehle, T. & Dermody, T. S. The sweet spot: defining virus-sialic acid interactions. Nat. Rev. Microbiol. 12, 739\u2013749 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"74633_CR60","doi-asserted-by":"crossref","unstructured":"Yang, F. et al. Discovery of a novel specific inhibitor targeting influenza A virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle. J. Virol. 95, e01432-20 (2021).","DOI":"10.1128\/JVI.01432-20"},{"key":"74633_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103762","volume":"75","author":"R Zhou","year":"2022","unstructured":"Zhou, R. et al. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models. EBioMedicine 75, 103762 (2022).","journal-title":"EBioMedicine"},{"key":"74633_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101151","volume":"3","author":"IE Galani","year":"2022","unstructured":"Galani, I. E., Triantafyllia, V., Eleminiadou, E. E. & Andreakos, E. Protocol for influenza A virus infection of mice and viral load determination. STAR Protoc. 3, 101151 (2022).","journal-title":"STAR Protoc."},{"key":"74633_CR63","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1097\/00003246-199711000-00030","volume":"25","author":"KM Smith","year":"1997","unstructured":"Smith, K. M. et al. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit. Care Med. 25, 1888\u20131897 (1997).","journal-title":"Crit. Care Med"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74633-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:04:52Z","timestamp":1786363492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74633-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74633"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74633-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interest(s): authors Z.C., R.J., and R.Z. have filed a US provisional patent application for the method (No. 63\/879,948). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8076"}}